Abstract
BackgroundNatural killer (NK) cell therapies have shown a great promise for solid and liquid tumors in initial clinical trials. NK cells are innate immune cells with distinct potential safety and...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
